Play

The world's first Platform-as-a-Service for digital biomarkers.

Most digital biomarkers stay stuck in the lab because moving to clinical use is too expensive and slow. WeGuide Biomarkers is a complete platform that handles the tech, the data, and the regulatory hurdles, so you can turn your research into a tool doctors can actually use.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.

10x

Cost Reduction

Skip the high cost and risk of building from scratch.

12%

Faster validation

Move from a raw idea to a clinical tool in weeks, not years.

Class IIb

TGA ready

Skip the regulatory headache with a platform built for medicalgrade apps.

13485

ISO compliant

Your data is protected by global standards for safety and quality.

Problems

Why digital biomarkers are
so hard to build

Trial execution relies on expensive, manual data collection.

WeGuide replaces slow, clinic-based data capture with automated digital workflows. This allows you to effortlessly collect continuous, real-world data and scale your research without scaling your operational overhead.

Fragmented data integration requires highly technical, bespoke engineering.

Our platform seamlessly harmonizes diverse, multi-modal datasets like wearables, accelerometers, and patient reported outcomes into a single, unified environment, completely eliminating complex IT bottlenecks.

Algorithm development requires time consuming, PhD-level trial and error.

We provide the built-in, scalable tools and standardized infrastructure needed to rapidly design, test, and validate digital biomarkers, freeing you from the trap of costly, bespoke software builds.

Commercial distribution is a complex, costly regulatory maze.

As a Class IIb certified platform, WeGuide shoulders the heavy compliance burden (TGA and EU MDR). We empower you to bypass regulatory roadblocks and instantly deploy approved biomarkers for real-world clinical use.

Solution

Build your biomarker, gather
evidence and commerclise

Rapidly design and configure complex studies in one place.

Set up your study without the technical friction. Easily define and configure all the critical data points you need to collect from patient-reported forms and clinical tests to remote wearables using our intuitive, centralised platform.

Capture unified, multimodal data with automated workflows.

Utilise WeGuide Engage to build your required dataset effortlessly. Keep participants and clinicians actively involved through automated prompts, ensuring high compliance and consistent data capture across all modalities.

Evaluate clinical algorithms instantly with AI-powered tools.

Bypass the technical bottlenecks with our biomarker development studio. Seamlessly create, score, and evaluate complex algorithms with the click of a button, turning raw data into validated insights without bespoke coding.

Distribute directly via our Class IIb certified platform.

Seamlessly transition from research to revenue. Commercialise your digital biomarker instantly on our regulatory approved infrastructure, making it immediately available for pharma, clinical trials, and real-world interventions.

A video is worth a thousand words

Everything you need to turn
research into Biomakers

Digital biomarkers?

Simple tools for a complex world

A digital biomarker is just a way of using technology like a smartwatch or a mobile app to track a person's health in their own home. Instead of a patient coming into a clinic once every six months, you can see how they are actually doing every single day.

It is about moving from a "guess" to "data." Whether it is tracking how someone walks after a stroke or monitoring heart rate during a trial, digital biomarkers give you a clear, continuous picture of a patient’s recovery.

Learn More

Helping researchers transform
ideas into discoveries.

Hear what our clients have to say!

Susan Clifford

Senior Research Officer

"WeGuide has transformed how we engage with our community. The platform made it simple to launch our air quality monitoring study across 15 neighborhoods in just three weeks."

Kaya Gardiner

Trial Project Manager

"The multilingual support was game-changing. We reached citizens who were previously excluded from research opportunities, resulting in a truly representative dataset."

Frequently asked questions

How is this different from a custom-built app?

A custom build is a one-off project that is hard to maintain and update. WeGuide is a scalable platform, meaning you get all the benefits of our ongoing security updates and regulatory work without the $3M price tag.

Can I use my own AI models?

Yes. Our studio is a sandbox where you can implement your own logic. We provide the tools to help you refine and validate those models against clinical gold standards.

Is the platform secure?

Security is our priority. We are Australian-owned and operated, and our infrastructure is fully compliant with the Privacy Act and international standards like ISO 27001.

Do you support regional and remote research?

Absolutely. By moving testing from the clinic to the home (BYOD), you can reach participants anywhere in Australia from the middle of Sydney to regional WA.

How does the royalty model work?

When you commercialise a biomarker through our marketplace, WeGuide takes a 30% royalty to cover the ongoing regulatory and hosting costs, while you keep the majority of the revenue.

What biomarkers are already on the platform?

We are currently working on biomarkers for mobility recovery, women's health, and more. Our partnership with NeuRA is the first of many validated tools available for distribution.

Never miss an update

Get all the latest news, blog posts and product updates from WeGuide, delivered directly to your inbox. We'll rarely send more than one email a month.